source name	characteristics[organism]	characteristics[organism part]	characteristics[cell line]	characteristics[ancestry category]	characteristics[age]	characteristics[sex]	characteristics[disease]	characteristics[cell type]	characteristics[developmental stage]	Material Type	assay name	Technology Type	comment[file uri]	comment[fraction identifier]	comment[label]	comment[cleavage agent details]	comment [cleavage agent details]	comment[fractionation method]	comment[instrument]	comment[separation]	comment[modification parameters]	comment[modification parameters]	comment[modification parameters]	comment[modification parameters]	comment[modification parameters]	comment[modification parameters]	comment[modification parameters]	comment[dissociation method]	comment[fragment mass tolerance]	comment[precursor mass tolerance]	comment[data file]	factor value[cell line]
Sample 9	Homo sapiens	cervix	HeLa	Black	31Y	Female	epithelial cervix carcinoma	epithelial	adult	cell line	run 298	proteomic profiling by mass spectrometry	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150911_QE7_UPLC11_DBJ_SA_HELA_3MG_50FRAC_TiO2_1.raw	1	AC=MS:1002038;NT=label free sample	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	AC=PRIDE:0000564; NT=High-pH reversed-phase chromatography	NT=Q Exactive;AC=MS:1001911	NT=High-pH reversed-phase chromatography;AC=PRIDE:0000564	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Glu->pyro-Glu; MT=Variable; PP=Anywhere; AC=UNIMOD:27; TA=Q	not available	not available	not available	AC=MS:1000422;NT=HCD	20 ppm	6 ppm	20150911_QE7_UPLC11_DBJ_SA_HELA_3MG_50FRAC_TiO2_1.raw	HeLa
Sample 9	Homo sapiens	cervix	HeLa	Black	31Y	Female	epithelial cervix carcinoma	epithelial	adult	cell line	run 299	proteomic profiling by mass spectrometry	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150911_QE7_UPLC11_DBJ_SA_HELA_3MG_50FRAC_TiO2_2.raw	2	AC=MS:1002038;NT=label free sample	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	AC=PRIDE:0000564; NT=High-pH reversed-phase chromatography	NT=Q Exactive;AC=MS:1001911	NT=High-pH reversed-phase chromatography;AC=PRIDE:0000564	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Glu->pyro-Glu; MT=Variable; PP=Anywhere; AC=UNIMOD:27; TA=Q	not available	not available	not available	AC=MS:1000422;NT=HCD	20 ppm	6 ppm	20150911_QE7_UPLC11_DBJ_SA_HELA_3MG_50FRAC_TiO2_2.raw	HeLa
Sample 9	Homo sapiens	cervix	HeLa	Black	31Y	Female	epithelial cervix carcinoma	epithelial	adult	cell line	run 300	proteomic profiling by mass spectrometry	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150911_QE7_UPLC11_DBJ_SA_HELA_3MG_50FRAC_TiO2_3.raw	3	AC=MS:1002038;NT=label free sample	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	AC=PRIDE:0000564; NT=High-pH reversed-phase chromatography	NT=Q Exactive;AC=MS:1001911	NT=High-pH reversed-phase chromatography;AC=PRIDE:0000564	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Glu->pyro-Glu; MT=Variable; PP=Anywhere; AC=UNIMOD:27; TA=Q	not available	not available	not available	AC=MS:1000422;NT=HCD	20 ppm	6 ppm	20150911_QE7_UPLC11_DBJ_SA_HELA_3MG_50FRAC_TiO2_3.raw	HeLa
Sample 9	Homo sapiens	cervix	HeLa	Black	31Y	Female	epithelial cervix carcinoma	epithelial	adult	cell line	run 301	proteomic profiling by mass spectrometry	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150911_QE7_UPLC11_DBJ_SA_HELA_3MG_50FRAC_TiO2_4.raw	4	AC=MS:1002038;NT=label free sample	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	AC=PRIDE:0000564; NT=High-pH reversed-phase chromatography	NT=Q Exactive;AC=MS:1001911	NT=High-pH reversed-phase chromatography;AC=PRIDE:0000564	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Glu->pyro-Glu; MT=Variable; PP=Anywhere; AC=UNIMOD:27; TA=Q	not available	not available	not available	AC=MS:1000422;NT=HCD	20 ppm	6 ppm	20150911_QE7_UPLC11_DBJ_SA_HELA_3MG_50FRAC_TiO2_4.raw	HeLa
Sample 9	Homo sapiens	cervix	HeLa	Black	31Y	Female	epithelial cervix carcinoma	epithelial	adult	cell line	run 302	proteomic profiling by mass spectrometry	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150911_QE7_UPLC11_DBJ_SA_HELA_3MG_50FRAC_TiO2_5.raw	5	AC=MS:1002038;NT=label free sample	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	AC=PRIDE:0000564; NT=High-pH reversed-phase chromatography	NT=Q Exactive;AC=MS:1001911	NT=High-pH reversed-phase chromatography;AC=PRIDE:0000564	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Glu->pyro-Glu; MT=Variable; PP=Anywhere; AC=UNIMOD:27; TA=Q	not available	not available	not available	AC=MS:1000422;NT=HCD	20 ppm	6 ppm	20150911_QE7_UPLC11_DBJ_SA_HELA_3MG_50FRAC_TiO2_5.raw	HeLa
Sample 9	Homo sapiens	cervix	HeLa	Black	31Y	Female	epithelial cervix carcinoma	epithelial	adult	cell line	run 303	proteomic profiling by mass spectrometry	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150911_QE7_UPLC11_DBJ_SA_HELA_3MG_50FRAC_TiO2_6.raw	6	AC=MS:1002038;NT=label free sample	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	AC=PRIDE:0000564; NT=High-pH reversed-phase chromatography	NT=Q Exactive;AC=MS:1001911	NT=High-pH reversed-phase chromatography;AC=PRIDE:0000564	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Glu->pyro-Glu; MT=Variable; PP=Anywhere; AC=UNIMOD:27; TA=Q	not available	not available	not available	AC=MS:1000422;NT=HCD	20 ppm	6 ppm	20150911_QE7_UPLC11_DBJ_SA_HELA_3MG_50FRAC_TiO2_6.raw	HeLa
Sample 9	Homo sapiens	cervix	HeLa	Black	31Y	Female	epithelial cervix carcinoma	epithelial	adult	cell line	run 304	proteomic profiling by mass spectrometry	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150911_QE7_UPLC11_DBJ_SA_HELA_3MG_50FRAC_TiO2_7.raw	7	AC=MS:1002038;NT=label free sample	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	AC=PRIDE:0000564; NT=High-pH reversed-phase chromatography	NT=Q Exactive;AC=MS:1001911	NT=High-pH reversed-phase chromatography;AC=PRIDE:0000564	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Glu->pyro-Glu; MT=Variable; PP=Anywhere; AC=UNIMOD:27; TA=Q	not available	not available	not available	AC=MS:1000422;NT=HCD	20 ppm	6 ppm	20150911_QE7_UPLC11_DBJ_SA_HELA_3MG_50FRAC_TiO2_7.raw	HeLa
Sample 9	Homo sapiens	cervix	HeLa	Black	31Y	Female	epithelial cervix carcinoma	epithelial	adult	cell line	run 305	proteomic profiling by mass spectrometry	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150911_QE7_UPLC11_DBJ_SA_HELA_3MG_50FRAC_TiO2_8.raw	8	AC=MS:1002038;NT=label free sample	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	AC=PRIDE:0000564; NT=High-pH reversed-phase chromatography	NT=Q Exactive;AC=MS:1001911	NT=High-pH reversed-phase chromatography;AC=PRIDE:0000564	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Glu->pyro-Glu; MT=Variable; PP=Anywhere; AC=UNIMOD:27; TA=Q	not available	not available	not available	AC=MS:1000422;NT=HCD	20 ppm	6 ppm	20150911_QE7_UPLC11_DBJ_SA_HELA_3MG_50FRAC_TiO2_8.raw	HeLa
Sample 9	Homo sapiens	cervix	HeLa	Black	31Y	Female	epithelial cervix carcinoma	epithelial	adult	cell line	run 306	proteomic profiling by mass spectrometry	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150911_QE7_UPLC11_DBJ_SA_HELA_3MG_50FRAC_TiO2_9.raw	9	AC=MS:1002038;NT=label free sample	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	AC=PRIDE:0000564; NT=High-pH reversed-phase chromatography	NT=Q Exactive;AC=MS:1001911	NT=High-pH reversed-phase chromatography;AC=PRIDE:0000564	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Glu->pyro-Glu; MT=Variable; PP=Anywhere; AC=UNIMOD:27; TA=Q	not available	not available	not available	AC=MS:1000422;NT=HCD	20 ppm	6 ppm	20150911_QE7_UPLC11_DBJ_SA_HELA_3MG_50FRAC_TiO2_9.raw	HeLa
Sample 9	Homo sapiens	cervix	HeLa	Black	31Y	Female	epithelial cervix carcinoma	epithelial	adult	cell line	run 307	proteomic profiling by mass spectrometry	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150911_QE7_UPLC11_DBJ_SA_HELA_3MG_50FRAC_TiO2_10.raw	10	AC=MS:1002038;NT=label free sample	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	AC=PRIDE:0000564; NT=High-pH reversed-phase chromatography	NT=Q Exactive;AC=MS:1001911	NT=High-pH reversed-phase chromatography;AC=PRIDE:0000564	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Glu->pyro-Glu; MT=Variable; PP=Anywhere; AC=UNIMOD:27; TA=Q	not available	not available	not available	AC=MS:1000422;NT=HCD	20 ppm	6 ppm	20150911_QE7_UPLC11_DBJ_SA_HELA_3MG_50FRAC_TiO2_10.raw	HeLa
Sample 9	Homo sapiens	cervix	HeLa	Black	31Y	Female	epithelial cervix carcinoma	epithelial	adult	cell line	run 308	proteomic profiling by mass spectrometry	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150911_QE7_UPLC11_DBJ_SA_HELA_3MG_50FRAC_TiO2_11.raw	11	AC=MS:1002038;NT=label free sample	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	AC=PRIDE:0000564; NT=High-pH reversed-phase chromatography	NT=Q Exactive;AC=MS:1001911	NT=High-pH reversed-phase chromatography;AC=PRIDE:0000564	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Glu->pyro-Glu; MT=Variable; PP=Anywhere; AC=UNIMOD:27; TA=Q	not available	not available	not available	AC=MS:1000422;NT=HCD	20 ppm	6 ppm	20150911_QE7_UPLC11_DBJ_SA_HELA_3MG_50FRAC_TiO2_11.raw	HeLa
Sample 9	Homo sapiens	cervix	HeLa	Black	31Y	Female	epithelial cervix carcinoma	epithelial	adult	cell line	run 309	proteomic profiling by mass spectrometry	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150911_QE7_UPLC11_DBJ_SA_HELA_3MG_50FRAC_TiO2_12.raw	12	AC=MS:1002038;NT=label free sample	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	AC=PRIDE:0000564; NT=High-pH reversed-phase chromatography	NT=Q Exactive;AC=MS:1001911	NT=High-pH reversed-phase chromatography;AC=PRIDE:0000564	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Glu->pyro-Glu; MT=Variable; PP=Anywhere; AC=UNIMOD:27; TA=Q	not available	not available	not available	AC=MS:1000422;NT=HCD	20 ppm	6 ppm	20150911_QE7_UPLC11_DBJ_SA_HELA_3MG_50FRAC_TiO2_12.raw	HeLa
Sample 9	Homo sapiens	cervix	HeLa	Black	31Y	Female	epithelial cervix carcinoma	epithelial	adult	cell line	run 310	proteomic profiling by mass spectrometry	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150911_QE7_UPLC11_DBJ_SA_HELA_3MG_50FRAC_TiO2_13.raw	13	AC=MS:1002038;NT=label free sample	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	AC=PRIDE:0000564; NT=High-pH reversed-phase chromatography	NT=Q Exactive;AC=MS:1001911	NT=High-pH reversed-phase chromatography;AC=PRIDE:0000564	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Glu->pyro-Glu; MT=Variable; PP=Anywhere; AC=UNIMOD:27; TA=Q	not available	not available	not available	AC=MS:1000422;NT=HCD	20 ppm	6 ppm	20150911_QE7_UPLC11_DBJ_SA_HELA_3MG_50FRAC_TiO2_13.raw	HeLa
Sample 9	Homo sapiens	cervix	HeLa	Black	31Y	Female	epithelial cervix carcinoma	epithelial	adult	cell line	run 311	proteomic profiling by mass spectrometry	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150911_QE7_UPLC11_DBJ_SA_HELA_3MG_50FRAC_TiO2_14.raw	14	AC=MS:1002038;NT=label free sample	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	AC=PRIDE:0000564; NT=High-pH reversed-phase chromatography	NT=Q Exactive;AC=MS:1001911	NT=High-pH reversed-phase chromatography;AC=PRIDE:0000564	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Glu->pyro-Glu; MT=Variable; PP=Anywhere; AC=UNIMOD:27; TA=Q	not available	not available	not available	AC=MS:1000422;NT=HCD	20 ppm	6 ppm	20150911_QE7_UPLC11_DBJ_SA_HELA_3MG_50FRAC_TiO2_14.raw	HeLa
Sample 9	Homo sapiens	cervix	HeLa	Black	31Y	Female	epithelial cervix carcinoma	epithelial	adult	cell line	run 312	proteomic profiling by mass spectrometry	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150911_QE7_UPLC11_DBJ_SA_HELA_3MG_50FRAC_TiO2_15.raw	15	AC=MS:1002038;NT=label free sample	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	AC=PRIDE:0000564; NT=High-pH reversed-phase chromatography	NT=Q Exactive;AC=MS:1001911	NT=High-pH reversed-phase chromatography;AC=PRIDE:0000564	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Glu->pyro-Glu; MT=Variable; PP=Anywhere; AC=UNIMOD:27; TA=Q	not available	not available	not available	AC=MS:1000422;NT=HCD	20 ppm	6 ppm	20150911_QE7_UPLC11_DBJ_SA_HELA_3MG_50FRAC_TiO2_15.raw	HeLa
Sample 9	Homo sapiens	cervix	HeLa	Black	31Y	Female	epithelial cervix carcinoma	epithelial	adult	cell line	run 313	proteomic profiling by mass spectrometry	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150911_QE7_UPLC11_DBJ_SA_HELA_3MG_50FRAC_TiO2_16.raw	16	AC=MS:1002038;NT=label free sample	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	AC=PRIDE:0000564; NT=High-pH reversed-phase chromatography	NT=Q Exactive;AC=MS:1001911	NT=High-pH reversed-phase chromatography;AC=PRIDE:0000564	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Glu->pyro-Glu; MT=Variable; PP=Anywhere; AC=UNIMOD:27; TA=Q	not available	not available	not available	AC=MS:1000422;NT=HCD	20 ppm	6 ppm	20150911_QE7_UPLC11_DBJ_SA_HELA_3MG_50FRAC_TiO2_16.raw	HeLa
Sample 9	Homo sapiens	cervix	HeLa	Black	31Y	Female	epithelial cervix carcinoma	epithelial	adult	cell line	run 314	proteomic profiling by mass spectrometry	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150911_QE7_UPLC11_DBJ_SA_HELA_3MG_50FRAC_TiO2_17.raw	17	AC=MS:1002038;NT=label free sample	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	AC=PRIDE:0000564; NT=High-pH reversed-phase chromatography	NT=Q Exactive;AC=MS:1001911	NT=High-pH reversed-phase chromatography;AC=PRIDE:0000564	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Glu->pyro-Glu; MT=Variable; PP=Anywhere; AC=UNIMOD:27; TA=Q	not available	not available	not available	AC=MS:1000422;NT=HCD	20 ppm	6 ppm	20150911_QE7_UPLC11_DBJ_SA_HELA_3MG_50FRAC_TiO2_17.raw	HeLa
Sample 9	Homo sapiens	cervix	HeLa	Black	31Y	Female	epithelial cervix carcinoma	epithelial	adult	cell line	run 315	proteomic profiling by mass spectrometry	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150911_QE7_UPLC11_DBJ_SA_HELA_3MG_50FRAC_TiO2_18.raw	18	AC=MS:1002038;NT=label free sample	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	AC=PRIDE:0000564; NT=High-pH reversed-phase chromatography	NT=Q Exactive;AC=MS:1001911	NT=High-pH reversed-phase chromatography;AC=PRIDE:0000564	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Glu->pyro-Glu; MT=Variable; PP=Anywhere; AC=UNIMOD:27; TA=Q	not available	not available	not available	AC=MS:1000422;NT=HCD	20 ppm	6 ppm	20150911_QE7_UPLC11_DBJ_SA_HELA_3MG_50FRAC_TiO2_18.raw	HeLa
Sample 9	Homo sapiens	cervix	HeLa	Black	31Y	Female	epithelial cervix carcinoma	epithelial	adult	cell line	run 316	proteomic profiling by mass spectrometry	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150911_QE7_UPLC11_DBJ_SA_HELA_3MG_50FRAC_TiO2_19.raw	19	AC=MS:1002038;NT=label free sample	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	AC=PRIDE:0000564; NT=High-pH reversed-phase chromatography	NT=Q Exactive;AC=MS:1001911	NT=High-pH reversed-phase chromatography;AC=PRIDE:0000564	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Glu->pyro-Glu; MT=Variable; PP=Anywhere; AC=UNIMOD:27; TA=Q	not available	not available	not available	AC=MS:1000422;NT=HCD	20 ppm	6 ppm	20150911_QE7_UPLC11_DBJ_SA_HELA_3MG_50FRAC_TiO2_19.raw	HeLa
Sample 9	Homo sapiens	cervix	HeLa	Black	31Y	Female	epithelial cervix carcinoma	epithelial	adult	cell line	run 317	proteomic profiling by mass spectrometry	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150911_QE7_UPLC11_DBJ_SA_HELA_3MG_50FRAC_TiO2_20.raw	20	AC=MS:1002038;NT=label free sample	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	AC=PRIDE:0000564; NT=High-pH reversed-phase chromatography	NT=Q Exactive;AC=MS:1001911	NT=High-pH reversed-phase chromatography;AC=PRIDE:0000564	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Glu->pyro-Glu; MT=Variable; PP=Anywhere; AC=UNIMOD:27; TA=Q	not available	not available	not available	AC=MS:1000422;NT=HCD	20 ppm	6 ppm	20150911_QE7_UPLC11_DBJ_SA_HELA_3MG_50FRAC_TiO2_20.raw	HeLa
Sample 9	Homo sapiens	cervix	HeLa	Black	31Y	Female	epithelial cervix carcinoma	epithelial	adult	cell line	run 318	proteomic profiling by mass spectrometry	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150911_QE7_UPLC11_DBJ_SA_HELA_3MG_50FRAC_TiO2_21.raw	21	AC=MS:1002038;NT=label free sample	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	AC=PRIDE:0000564; NT=High-pH reversed-phase chromatography	NT=Q Exactive;AC=MS:1001911	NT=High-pH reversed-phase chromatography;AC=PRIDE:0000564	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Glu->pyro-Glu; MT=Variable; PP=Anywhere; AC=UNIMOD:27; TA=Q	not available	not available	not available	AC=MS:1000422;NT=HCD	20 ppm	6 ppm	20150911_QE7_UPLC11_DBJ_SA_HELA_3MG_50FRAC_TiO2_21.raw	HeLa
Sample 9	Homo sapiens	cervix	HeLa	Black	31Y	Female	epithelial cervix carcinoma	epithelial	adult	cell line	run 319	proteomic profiling by mass spectrometry	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150911_QE7_UPLC11_DBJ_SA_HELA_3MG_50FRAC_TiO2_22.raw	22	AC=MS:1002038;NT=label free sample	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	AC=PRIDE:0000564; NT=High-pH reversed-phase chromatography	NT=Q Exactive;AC=MS:1001911	NT=High-pH reversed-phase chromatography;AC=PRIDE:0000564	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Glu->pyro-Glu; MT=Variable; PP=Anywhere; AC=UNIMOD:27; TA=Q	not available	not available	not available	AC=MS:1000422;NT=HCD	20 ppm	6 ppm	20150911_QE7_UPLC11_DBJ_SA_HELA_3MG_50FRAC_TiO2_22.raw	HeLa
Sample 9	Homo sapiens	cervix	HeLa	Black	31Y	Female	epithelial cervix carcinoma	epithelial	adult	cell line	run 320	proteomic profiling by mass spectrometry	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150911_QE7_UPLC11_DBJ_SA_HELA_3MG_50FRAC_TiO2_23.raw	23	AC=MS:1002038;NT=label free sample	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	AC=PRIDE:0000564; NT=High-pH reversed-phase chromatography	NT=Q Exactive;AC=MS:1001911	NT=High-pH reversed-phase chromatography;AC=PRIDE:0000564	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Glu->pyro-Glu; MT=Variable; PP=Anywhere; AC=UNIMOD:27; TA=Q	not available	not available	not available	AC=MS:1000422;NT=HCD	20 ppm	6 ppm	20150911_QE7_UPLC11_DBJ_SA_HELA_3MG_50FRAC_TiO2_23.raw	HeLa
Sample 9	Homo sapiens	cervix	HeLa	Black	31Y	Female	epithelial cervix carcinoma	epithelial	adult	cell line	run 321	proteomic profiling by mass spectrometry	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150911_QE7_UPLC11_DBJ_SA_HELA_3MG_50FRAC_TiO2_24.raw	24	AC=MS:1002038;NT=label free sample	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	AC=PRIDE:0000564; NT=High-pH reversed-phase chromatography	NT=Q Exactive;AC=MS:1001911	NT=High-pH reversed-phase chromatography;AC=PRIDE:0000564	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Glu->pyro-Glu; MT=Variable; PP=Anywhere; AC=UNIMOD:27; TA=Q	not available	not available	not available	AC=MS:1000422;NT=HCD	20 ppm	6 ppm	20150911_QE7_UPLC11_DBJ_SA_HELA_3MG_50FRAC_TiO2_24.raw	HeLa
Sample 9	Homo sapiens	cervix	HeLa	Black	31Y	Female	epithelial cervix carcinoma	epithelial	adult	cell line	run 322	proteomic profiling by mass spectrometry	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150911_QE7_UPLC11_DBJ_SA_HELA_3MG_50FRAC_TiO2_25.raw	25	AC=MS:1002038;NT=label free sample	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	AC=PRIDE:0000564; NT=High-pH reversed-phase chromatography	NT=Q Exactive;AC=MS:1001911	NT=High-pH reversed-phase chromatography;AC=PRIDE:0000564	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Glu->pyro-Glu; MT=Variable; PP=Anywhere; AC=UNIMOD:27; TA=Q	not available	not available	not available	AC=MS:1000422;NT=HCD	20 ppm	6 ppm	20150911_QE7_UPLC11_DBJ_SA_HELA_3MG_50FRAC_TiO2_25.raw	HeLa
Sample 9	Homo sapiens	cervix	HeLa	Black	31Y	Female	epithelial cervix carcinoma	epithelial	adult	cell line	run 323	proteomic profiling by mass spectrometry	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150911_QE7_UPLC11_DBJ_SA_HELA_3MG_50FRAC_TiO2_26.raw	26	AC=MS:1002038;NT=label free sample	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	AC=PRIDE:0000564; NT=High-pH reversed-phase chromatography	NT=Q Exactive;AC=MS:1001911	NT=High-pH reversed-phase chromatography;AC=PRIDE:0000564	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Glu->pyro-Glu; MT=Variable; PP=Anywhere; AC=UNIMOD:27; TA=Q	not available	not available	not available	AC=MS:1000422;NT=HCD	20 ppm	6 ppm	20150911_QE7_UPLC11_DBJ_SA_HELA_3MG_50FRAC_TiO2_26.raw	HeLa
Sample 9	Homo sapiens	cervix	HeLa	Black	31Y	Female	epithelial cervix carcinoma	epithelial	adult	cell line	run 324	proteomic profiling by mass spectrometry	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150911_QE7_UPLC11_DBJ_SA_HELA_3MG_50FRAC_TiO2_27.raw	27	AC=MS:1002038;NT=label free sample	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	AC=PRIDE:0000564; NT=High-pH reversed-phase chromatography	NT=Q Exactive;AC=MS:1001911	NT=High-pH reversed-phase chromatography;AC=PRIDE:0000564	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Glu->pyro-Glu; MT=Variable; PP=Anywhere; AC=UNIMOD:27; TA=Q	not available	not available	not available	AC=MS:1000422;NT=HCD	20 ppm	6 ppm	20150911_QE7_UPLC11_DBJ_SA_HELA_3MG_50FRAC_TiO2_27.raw	HeLa
Sample 9	Homo sapiens	cervix	HeLa	Black	31Y	Female	epithelial cervix carcinoma	epithelial	adult	cell line	run 325	proteomic profiling by mass spectrometry	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150911_QE7_UPLC11_DBJ_SA_HELA_3MG_50FRAC_TiO2_28.raw	28	AC=MS:1002038;NT=label free sample	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	AC=PRIDE:0000564; NT=High-pH reversed-phase chromatography	NT=Q Exactive;AC=MS:1001911	NT=High-pH reversed-phase chromatography;AC=PRIDE:0000564	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Glu->pyro-Glu; MT=Variable; PP=Anywhere; AC=UNIMOD:27; TA=Q	not available	not available	not available	AC=MS:1000422;NT=HCD	20 ppm	6 ppm	20150911_QE7_UPLC11_DBJ_SA_HELA_3MG_50FRAC_TiO2_28.raw	HeLa
Sample 9	Homo sapiens	cervix	HeLa	Black	31Y	Female	epithelial cervix carcinoma	epithelial	adult	cell line	run 326	proteomic profiling by mass spectrometry	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150911_QE7_UPLC11_DBJ_SA_HELA_3MG_50FRAC_TiO2_29.raw	29	AC=MS:1002038;NT=label free sample	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	AC=PRIDE:0000564; NT=High-pH reversed-phase chromatography	NT=Q Exactive;AC=MS:1001911	NT=High-pH reversed-phase chromatography;AC=PRIDE:0000564	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Glu->pyro-Glu; MT=Variable; PP=Anywhere; AC=UNIMOD:27; TA=Q	not available	not available	not available	AC=MS:1000422;NT=HCD	20 ppm	6 ppm	20150911_QE7_UPLC11_DBJ_SA_HELA_3MG_50FRAC_TiO2_29.raw	HeLa
Sample 9	Homo sapiens	cervix	HeLa	Black	31Y	Female	epithelial cervix carcinoma	epithelial	adult	cell line	run 327	proteomic profiling by mass spectrometry	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150911_QE7_UPLC11_DBJ_SA_HELA_3MG_50FRAC_TiO2_30.raw	30	AC=MS:1002038;NT=label free sample	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	AC=PRIDE:0000564; NT=High-pH reversed-phase chromatography	NT=Q Exactive;AC=MS:1001911	NT=High-pH reversed-phase chromatography;AC=PRIDE:0000564	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Glu->pyro-Glu; MT=Variable; PP=Anywhere; AC=UNIMOD:27; TA=Q	not available	not available	not available	AC=MS:1000422;NT=HCD	20 ppm	6 ppm	20150911_QE7_UPLC11_DBJ_SA_HELA_3MG_50FRAC_TiO2_30.raw	HeLa
Sample 9	Homo sapiens	cervix	HeLa	Black	31Y	Female	epithelial cervix carcinoma	epithelial	adult	cell line	run 328	proteomic profiling by mass spectrometry	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150911_QE7_UPLC11_DBJ_SA_HELA_3MG_50FRAC_TiO2_31.raw	31	AC=MS:1002038;NT=label free sample	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	AC=PRIDE:0000564; NT=High-pH reversed-phase chromatography	NT=Q Exactive;AC=MS:1001911	NT=High-pH reversed-phase chromatography;AC=PRIDE:0000564	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Glu->pyro-Glu; MT=Variable; PP=Anywhere; AC=UNIMOD:27; TA=Q	not available	not available	not available	AC=MS:1000422;NT=HCD	20 ppm	6 ppm	20150911_QE7_UPLC11_DBJ_SA_HELA_3MG_50FRAC_TiO2_31.raw	HeLa
Sample 9	Homo sapiens	cervix	HeLa	Black	31Y	Female	epithelial cervix carcinoma	epithelial	adult	cell line	run 329	proteomic profiling by mass spectrometry	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150911_QE7_UPLC11_DBJ_SA_HELA_3MG_50FRAC_TiO2_32.raw	32	AC=MS:1002038;NT=label free sample	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	AC=PRIDE:0000564; NT=High-pH reversed-phase chromatography	NT=Q Exactive;AC=MS:1001911	NT=High-pH reversed-phase chromatography;AC=PRIDE:0000564	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Glu->pyro-Glu; MT=Variable; PP=Anywhere; AC=UNIMOD:27; TA=Q	not available	not available	not available	AC=MS:1000422;NT=HCD	20 ppm	6 ppm	20150911_QE7_UPLC11_DBJ_SA_HELA_3MG_50FRAC_TiO2_32.raw	HeLa
Sample 9	Homo sapiens	cervix	HeLa	Black	31Y	Female	epithelial cervix carcinoma	epithelial	adult	cell line	run 330	proteomic profiling by mass spectrometry	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150911_QE7_UPLC11_DBJ_SA_HELA_3MG_50FRAC_TiO2_33.raw	33	AC=MS:1002038;NT=label free sample	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	AC=PRIDE:0000564; NT=High-pH reversed-phase chromatography	NT=Q Exactive;AC=MS:1001911	NT=High-pH reversed-phase chromatography;AC=PRIDE:0000564	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Glu->pyro-Glu; MT=Variable; PP=Anywhere; AC=UNIMOD:27; TA=Q	not available	not available	not available	AC=MS:1000422;NT=HCD	20 ppm	6 ppm	20150911_QE7_UPLC11_DBJ_SA_HELA_3MG_50FRAC_TiO2_33.raw	HeLa
Sample 9	Homo sapiens	cervix	HeLa	Black	31Y	Female	epithelial cervix carcinoma	epithelial	adult	cell line	run 331	proteomic profiling by mass spectrometry	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150911_QE7_UPLC11_DBJ_SA_HELA_3MG_50FRAC_TiO2_34.raw	34	AC=MS:1002038;NT=label free sample	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	AC=PRIDE:0000564; NT=High-pH reversed-phase chromatography	NT=Q Exactive;AC=MS:1001911	NT=High-pH reversed-phase chromatography;AC=PRIDE:0000564	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Glu->pyro-Glu; MT=Variable; PP=Anywhere; AC=UNIMOD:27; TA=Q	not available	not available	not available	AC=MS:1000422;NT=HCD	20 ppm	6 ppm	20150911_QE7_UPLC11_DBJ_SA_HELA_3MG_50FRAC_TiO2_34.raw	HeLa
Sample 9	Homo sapiens	cervix	HeLa	Black	31Y	Female	epithelial cervix carcinoma	epithelial	adult	cell line	run 332	proteomic profiling by mass spectrometry	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150911_QE7_UPLC11_DBJ_SA_HELA_3MG_50FRAC_TiO2_35.raw	35	AC=MS:1002038;NT=label free sample	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	AC=PRIDE:0000564; NT=High-pH reversed-phase chromatography	NT=Q Exactive;AC=MS:1001911	NT=High-pH reversed-phase chromatography;AC=PRIDE:0000564	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Glu->pyro-Glu; MT=Variable; PP=Anywhere; AC=UNIMOD:27; TA=Q	not available	not available	not available	AC=MS:1000422;NT=HCD	20 ppm	6 ppm	20150911_QE7_UPLC11_DBJ_SA_HELA_3MG_50FRAC_TiO2_35.raw	HeLa
Sample 9	Homo sapiens	cervix	HeLa	Black	31Y	Female	epithelial cervix carcinoma	epithelial	adult	cell line	run 333	proteomic profiling by mass spectrometry	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150911_QE7_UPLC11_DBJ_SA_HELA_3MG_50FRAC_TiO2_36.raw	36	AC=MS:1002038;NT=label free sample	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	AC=PRIDE:0000564; NT=High-pH reversed-phase chromatography	NT=Q Exactive;AC=MS:1001911	NT=High-pH reversed-phase chromatography;AC=PRIDE:0000564	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Glu->pyro-Glu; MT=Variable; PP=Anywhere; AC=UNIMOD:27; TA=Q	not available	not available	not available	AC=MS:1000422;NT=HCD	20 ppm	6 ppm	20150911_QE7_UPLC11_DBJ_SA_HELA_3MG_50FRAC_TiO2_36.raw	HeLa
Sample 9	Homo sapiens	cervix	HeLa	Black	31Y	Female	epithelial cervix carcinoma	epithelial	adult	cell line	run 334	proteomic profiling by mass spectrometry	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150911_QE7_UPLC11_DBJ_SA_HELA_3MG_50FRAC_TiO2_37.raw	37	AC=MS:1002038;NT=label free sample	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	AC=PRIDE:0000564; NT=High-pH reversed-phase chromatography	NT=Q Exactive;AC=MS:1001911	NT=High-pH reversed-phase chromatography;AC=PRIDE:0000564	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Glu->pyro-Glu; MT=Variable; PP=Anywhere; AC=UNIMOD:27; TA=Q	not available	not available	not available	AC=MS:1000422;NT=HCD	20 ppm	6 ppm	20150911_QE7_UPLC11_DBJ_SA_HELA_3MG_50FRAC_TiO2_37.raw	HeLa
Sample 9	Homo sapiens	cervix	HeLa	Black	31Y	Female	epithelial cervix carcinoma	epithelial	adult	cell line	run 335	proteomic profiling by mass spectrometry	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150911_QE7_UPLC11_DBJ_SA_HELA_3MG_50FRAC_TiO2_38.raw	38	AC=MS:1002038;NT=label free sample	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	AC=PRIDE:0000564; NT=High-pH reversed-phase chromatography	NT=Q Exactive;AC=MS:1001911	NT=High-pH reversed-phase chromatography;AC=PRIDE:0000564	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Glu->pyro-Glu; MT=Variable; PP=Anywhere; AC=UNIMOD:27; TA=Q	not available	not available	not available	AC=MS:1000422;NT=HCD	20 ppm	6 ppm	20150911_QE7_UPLC11_DBJ_SA_HELA_3MG_50FRAC_TiO2_38.raw	HeLa
Sample 9	Homo sapiens	cervix	HeLa	Black	31Y	Female	epithelial cervix carcinoma	epithelial	adult	cell line	run 336	proteomic profiling by mass spectrometry	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150911_QE7_UPLC11_DBJ_SA_HELA_3MG_50FRAC_TiO2_39.raw	39	AC=MS:1002038;NT=label free sample	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	AC=PRIDE:0000564; NT=High-pH reversed-phase chromatography	NT=Q Exactive;AC=MS:1001911	NT=High-pH reversed-phase chromatography;AC=PRIDE:0000564	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Glu->pyro-Glu; MT=Variable; PP=Anywhere; AC=UNIMOD:27; TA=Q	not available	not available	not available	AC=MS:1000422;NT=HCD	20 ppm	6 ppm	20150911_QE7_UPLC11_DBJ_SA_HELA_3MG_50FRAC_TiO2_39.raw	HeLa
Sample 9	Homo sapiens	cervix	HeLa	Black	31Y	Female	epithelial cervix carcinoma	epithelial	adult	cell line	run 337	proteomic profiling by mass spectrometry	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150911_QE7_UPLC11_DBJ_SA_HELA_3MG_50FRAC_TiO2_40.raw	40	AC=MS:1002038;NT=label free sample	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	AC=PRIDE:0000564; NT=High-pH reversed-phase chromatography	NT=Q Exactive;AC=MS:1001911	NT=High-pH reversed-phase chromatography;AC=PRIDE:0000564	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Glu->pyro-Glu; MT=Variable; PP=Anywhere; AC=UNIMOD:27; TA=Q	not available	not available	not available	AC=MS:1000422;NT=HCD	20 ppm	6 ppm	20150911_QE7_UPLC11_DBJ_SA_HELA_3MG_50FRAC_TiO2_40.raw	HeLa
Sample 9	Homo sapiens	cervix	HeLa	Black	31Y	Female	epithelial cervix carcinoma	epithelial	adult	cell line	run 338	proteomic profiling by mass spectrometry	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150911_QE7_UPLC11_DBJ_SA_HELA_3MG_50FRAC_TiO2_41.raw	41	AC=MS:1002038;NT=label free sample	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	AC=PRIDE:0000564; NT=High-pH reversed-phase chromatography	NT=Q Exactive;AC=MS:1001911	NT=High-pH reversed-phase chromatography;AC=PRIDE:0000564	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Glu->pyro-Glu; MT=Variable; PP=Anywhere; AC=UNIMOD:27; TA=Q	not available	not available	not available	AC=MS:1000422;NT=HCD	20 ppm	6 ppm	20150911_QE7_UPLC11_DBJ_SA_HELA_3MG_50FRAC_TiO2_41.raw	HeLa
Sample 9	Homo sapiens	cervix	HeLa	Black	31Y	Female	epithelial cervix carcinoma	epithelial	adult	cell line	run 339	proteomic profiling by mass spectrometry	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150911_QE7_UPLC11_DBJ_SA_HELA_3MG_50FRAC_TiO2_42.raw	42	AC=MS:1002038;NT=label free sample	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	AC=PRIDE:0000564; NT=High-pH reversed-phase chromatography	NT=Q Exactive;AC=MS:1001911	NT=High-pH reversed-phase chromatography;AC=PRIDE:0000564	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Glu->pyro-Glu; MT=Variable; PP=Anywhere; AC=UNIMOD:27; TA=Q	not available	not available	not available	AC=MS:1000422;NT=HCD	20 ppm	6 ppm	20150911_QE7_UPLC11_DBJ_SA_HELA_3MG_50FRAC_TiO2_42.raw	HeLa
Sample 9	Homo sapiens	cervix	HeLa	Black	31Y	Female	epithelial cervix carcinoma	epithelial	adult	cell line	run 340	proteomic profiling by mass spectrometry	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150911_QE7_UPLC11_DBJ_SA_HELA_3MG_50FRAC_TiO2_43.raw	43	AC=MS:1002038;NT=label free sample	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	AC=PRIDE:0000564; NT=High-pH reversed-phase chromatography	NT=Q Exactive;AC=MS:1001911	NT=High-pH reversed-phase chromatography;AC=PRIDE:0000564	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Glu->pyro-Glu; MT=Variable; PP=Anywhere; AC=UNIMOD:27; TA=Q	not available	not available	not available	AC=MS:1000422;NT=HCD	20 ppm	6 ppm	20150911_QE7_UPLC11_DBJ_SA_HELA_3MG_50FRAC_TiO2_43.raw	HeLa
Sample 9	Homo sapiens	cervix	HeLa	Black	31Y	Female	epithelial cervix carcinoma	epithelial	adult	cell line	run 341	proteomic profiling by mass spectrometry	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150911_QE7_UPLC11_DBJ_SA_HELA_3MG_50FRAC_TiO2_44.raw	44	AC=MS:1002038;NT=label free sample	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	AC=PRIDE:0000564; NT=High-pH reversed-phase chromatography	NT=Q Exactive;AC=MS:1001911	NT=High-pH reversed-phase chromatography;AC=PRIDE:0000564	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Glu->pyro-Glu; MT=Variable; PP=Anywhere; AC=UNIMOD:27; TA=Q	not available	not available	not available	AC=MS:1000422;NT=HCD	20 ppm	6 ppm	20150911_QE7_UPLC11_DBJ_SA_HELA_3MG_50FRAC_TiO2_44.raw	HeLa
Sample 9	Homo sapiens	cervix	HeLa	Black	31Y	Female	epithelial cervix carcinoma	epithelial	adult	cell line	run 342	proteomic profiling by mass spectrometry	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150911_QE7_UPLC11_DBJ_SA_HELA_3MG_50FRAC_TiO2_45.raw	45	AC=MS:1002038;NT=label free sample	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	AC=PRIDE:0000564; NT=High-pH reversed-phase chromatography	NT=Q Exactive;AC=MS:1001911	NT=High-pH reversed-phase chromatography;AC=PRIDE:0000564	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Glu->pyro-Glu; MT=Variable; PP=Anywhere; AC=UNIMOD:27; TA=Q	not available	not available	not available	AC=MS:1000422;NT=HCD	20 ppm	6 ppm	20150911_QE7_UPLC11_DBJ_SA_HELA_3MG_50FRAC_TiO2_45.raw	HeLa
Sample 9	Homo sapiens	cervix	HeLa	Black	31Y	Female	epithelial cervix carcinoma	epithelial	adult	cell line	run 343	proteomic profiling by mass spectrometry	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150911_QE7_UPLC11_DBJ_SA_HELA_3MG_50FRAC_TiO2_46.raw	46	AC=MS:1002038;NT=label free sample	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	AC=PRIDE:0000564; NT=High-pH reversed-phase chromatography	NT=Q Exactive;AC=MS:1001911	NT=High-pH reversed-phase chromatography;AC=PRIDE:0000564	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Glu->pyro-Glu; MT=Variable; PP=Anywhere; AC=UNIMOD:27; TA=Q	not available	not available	not available	AC=MS:1000422;NT=HCD	20 ppm	6 ppm	20150911_QE7_UPLC11_DBJ_SA_HELA_3MG_50FRAC_TiO2_46.raw	HeLa
Sample 9	Homo sapiens	cervix	HeLa	Black	31Y	Female	epithelial cervix carcinoma	epithelial	adult	cell line	run 344	proteomic profiling by mass spectrometry	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150911_QE7_UPLC11_DBJ_SA_HELA_3MG_50FRAC_TiO2_47.raw	47	AC=MS:1002038;NT=label free sample	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	AC=PRIDE:0000564; NT=High-pH reversed-phase chromatography	NT=Q Exactive;AC=MS:1001911	NT=High-pH reversed-phase chromatography;AC=PRIDE:0000564	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Glu->pyro-Glu; MT=Variable; PP=Anywhere; AC=UNIMOD:27; TA=Q	not available	not available	not available	AC=MS:1000422;NT=HCD	20 ppm	6 ppm	20150911_QE7_UPLC11_DBJ_SA_HELA_3MG_50FRAC_TiO2_47.raw	HeLa
Sample 9	Homo sapiens	cervix	HeLa	Black	31Y	Female	epithelial cervix carcinoma	epithelial	adult	cell line	run 345	proteomic profiling by mass spectrometry	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150911_QE7_UPLC11_DBJ_SA_HELA_3MG_50FRAC_TiO2_48.raw	48	AC=MS:1002038;NT=label free sample	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	AC=PRIDE:0000564; NT=High-pH reversed-phase chromatography	NT=Q Exactive;AC=MS:1001911	NT=High-pH reversed-phase chromatography;AC=PRIDE:0000564	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Glu->pyro-Glu; MT=Variable; PP=Anywhere; AC=UNIMOD:27; TA=Q	not available	not available	not available	AC=MS:1000422;NT=HCD	20 ppm	6 ppm	20150911_QE7_UPLC11_DBJ_SA_HELA_3MG_50FRAC_TiO2_48.raw	HeLa
Sample 9	Homo sapiens	cervix	HeLa	Black	31Y	Female	epithelial cervix carcinoma	epithelial	adult	cell line	run 346	proteomic profiling by mass spectrometry	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150911_QE7_UPLC11_DBJ_SA_HELA_3MG_50FRAC_TiO2_49.raw	49	AC=MS:1002038;NT=label free sample	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	AC=PRIDE:0000564; NT=High-pH reversed-phase chromatography	NT=Q Exactive;AC=MS:1001911	NT=High-pH reversed-phase chromatography;AC=PRIDE:0000564	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Glu->pyro-Glu; MT=Variable; PP=Anywhere; AC=UNIMOD:27; TA=Q	not available	not available	not available	AC=MS:1000422;NT=HCD	20 ppm	6 ppm	20150911_QE7_UPLC11_DBJ_SA_HELA_3MG_50FRAC_TiO2_49.raw	HeLa
Sample 9	Homo sapiens	cervix	HeLa	Black	31Y	Female	epithelial cervix carcinoma	epithelial	adult	cell line	run 347	proteomic profiling by mass spectrometry	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD004452/20150911_QE7_UPLC11_DBJ_SA_HELA_3MG_50FRAC_TiO2_50.raw	50	AC=MS:1002038;NT=label free sample	NT=Lys-C;AC=MS:1001309	NT=Trypsin;AC=MS:1001251	AC=PRIDE:0000564; NT=High-pH reversed-phase chromatography	NT=Q Exactive;AC=MS:1001911	NT=High-pH reversed-phase chromatography;AC=PRIDE:0000564	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=Variable	NT=Glu->pyro-Glu; MT=Variable; PP=Anywhere; AC=UNIMOD:27; TA=Q	not available	not available	not available	AC=MS:1000422;NT=HCD	20 ppm	6 ppm	20150911_QE7_UPLC11_DBJ_SA_HELA_3MG_50FRAC_TiO2_50.raw	HeLa
